Benitec Biopharma (BNTC) Share-based Compensation (2019 - 2025)
Benitec Biopharma (BNTC) posted Share-based Compensation of $37.8 million for Q4 2025, up 629.73% sequentially from $5.2 million in Q3 2025, and up 1104.59% YoY from $3.1 million in Q4 2024.
Benitec Biopharma (BNTC) Share-based Compensation (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Share-based Compensation for 7 years, with the latest figure at $37.8 million in Q4 2025.
- Quarterly Share-based Compensation rose 1104.59% year-over-year to $37.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.8 million (up 795.95% YoY) and the FY2025 annual result came in at $17.4 million, up 1999.52% from the prior year.
- Share-based Compensation rose to $37.8 million in Q4 2025 per BNTC's latest filing, from $5.2 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $37.8 million in Q4 2025 and troughed at -$92000.0 in Q1 2022.
- A 5-year average of $3.3 million and a median of $275000.0 in 2021 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation tumbled 139.15% in 2022, then jumped 3274.19% in 2024.
- Over 5 years, Share-based Compensation stood at $523000.0 in 2021, then sank by 109.18% to -$48000.0 in 2022, then jumped by 293.75% to $93000.0 in 2023, then surged by 3274.19% to $3.1 million in 2024, then soared by 1104.59% to $37.8 million in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $37.8 million, $5.2 million, and $13.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 37.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.80 Mn |
| Dec 31, 2025 | 37.80 Mn |
| Sep 30, 2025 | 5.18 Mn |
| Sep 30, 2025 | 5.18 Mn |
| Jun 30, 2025 | 13.45 Mn |
| Jun 30, 2025 | 13.45 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 435,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Sep 30, 2023 | 91,000.00 |
| Sep 30, 2023 | 91,000.00 |